Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
AAPS PharmSciTech ; 15(5): 1263-74, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24895077

RESUMO

A new vancomycin (VCM)-eluting mixed bilayer niosome formulation was evaluated for the control of staphylococcal colonization and biofilm formation on abiotic surfaces, a niosome application not explored to date. Cosurfactant niosomes were prepared using a Span 60/Tween 40/cholesterol blend (1: 1: 2). Tween 40, a polyethoxylated amphiphile, was included to enhance VCM entrapment and confer niosomal surface properties precluding bacterial adhesion. VCM-eluting niosomes showed good quality attributes including relatively high entrapment efficiency (∼50%), association of Tween 40 with vesicles in a constant proportion (∼87%), biphasic release profile suitable for inhibiting early bacterial colonization, and long-term stability at 4°C for a 12-month study period. Niosomes significantly enhanced VCM activity against planktonic bacteria of nine staphylococcal strains. Using microtiter plates as abiotic surface, VCM-eluting niosomes proved superior to VCM in inhibiting biofilm formation, eradicating surface-borne biofilms, inhibiting biofilm growth, and interfering with biofilm induction by VCM subminimal inhibitory concentrations. Data suggest dual functionality of cosurfactant VCM-eluting niosomes as passive colonization inhibiting barrier and active antimicrobial-controlled delivery system, two functions recognized in infection control of abiotic surfaces and medical devices.


Assuntos
Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Biofilmes/efeitos dos fármacos , Lipossomos/química , Staphylococcus aureus/efeitos dos fármacos , Vancomicina/administração & dosagem , Vancomicina/farmacologia , Biofilmes/crescimento & desenvolvimento , Eletroquímica , Excipientes , Testes de Sensibilidade Microbiana , Tamanho da Partícula , Polissorbatos , Staphylococcus aureus/crescimento & desenvolvimento
2.
Drug Dev Ind Pharm ; 35(5): 631-7, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-18989805

RESUMO

Marketed topical gels of the antifungal drug naftifine hydrochloride contain 50% alcohol as cosolvent. Repeated exposure to alcohol could be detrimental to skin. The aim of this study is to develop an alcohol-free niosome gel containing 1% naftifine hydrochloride. Niosomes were prepared and formulation variables were optimized to achieve maximum entrapment coupled with stability. Maximum drug entrapment and niosome stability entailed imparting a negative charge to the vesicles where entrapment efficiency reached 50%. Niosomes were incorporated into a hydroxyethylcellulose gel. The final gel contained a total drug concentration of 1% (wt/wt) half of which was entrapped in the niosomes. The results suggest the potential usefulness of the niosome gel.


Assuntos
Alilamina/análogos & derivados , Antifúngicos/administração & dosagem , Alilamina/administração & dosagem , Alilamina/química , Antifúngicos/química , Celulose/análogos & derivados , Química Farmacêutica , Estabilidade de Medicamentos , Excipientes , Géis , Lipossomos , Microscopia Eletrônica de Varredura , Organofosfatos/química , Tamanho da Partícula , Polissorbatos , Espectrofotometria Ultravioleta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...